Role of cytochrome P450 2C9 and an allelic variant in the 4'-hydroxylation of (R)- and (S)-flurbiprofen

Biochemical Pharmacology
T S TracyK R Korzekwa

Abstract

Flurbiprofen is a chiral non-steroidal anti-inflammatory drug used in the treatment of pain or inflammation. The primary routes of biotransformation for (R)- and (S)-flurbiprofen are oxidation (presumably cytochrome P450) and conjugation. To date, the specific cytochrome P450 (P450) involved in the oxidative metabolism of this compound (specifically 4'-hydroxylation) has not been elucidated. Experiments were conducted to characterize the kinetic parameters (Km and Vmax) for the 4'-hydroxylation of (R)- and (S)-flurbiprofen in human liver microsomes, to determine if enantiomeric interactions occur when both enantiomers are present, and to identify the specific P450 form(s) involved in this reaction. In human liver microsomes, the Km and Vmax (mean +/- SD) for (R)-4'-hydroxy-flurbiprofen formation were 3.1 +/- 0.8 microM and 305 +/- 168 pmol.min-1.mg protein)-1, respectively. In comparison, the Km and Vmax (mean +/- SD) for (S)-4'-hydroxy-flurbiprofen formation were 1.9 +/- 0.4 microM and 343 +/- 196 pmol.min-1.mg protein-1, respectively. Enantiomeric interaction studies revealed a decrease in Km and Vmax for both enantiomers and an apparent loss of stereoselectivity. Racemic-warfarin, tolbutamide, alpha-naphthoflavone and erythr...Continue Reading

References

Nov 1, 1978·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·P C RisdallB Marchant
Jan 1, 1979·Methods in Enzymology·W W Cleland
Jan 1, 1991·Methods in Enzymology·F J GonzalezH V Gelboin
Jan 1, 1990·Chirality·M P Knadler, S D Hall
Mar 24, 1986·The American Journal of Medicine·T G Kantor
Aug 1, 1988·Journal of Pharmaceutical Sciences·F JamaliA S Russell
May 1, 1987·Biopharmaceutics & Drug Disposition·G J SzpunarJ G Wagner
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·P B WatkinsP S Guzelian

Citations

Dec 17, 2009·JAMA : the Journal of the American Medical Association·Robert C GreenTarenflurbil Phase 3 Study Group
Jun 7, 2006·Veterinary Research Communications·L IgarzaH Zeballos
Jul 8, 2009·Applied Biochemistry and Biotechnology·Sepuri Asha, Maravajhala Vidyavathi
Dec 5, 2002·Archives of Biochemistry and Biophysics·David F V Lewis
Feb 1, 2003·Archives of Biochemistry and Biophysics·J M HutzlerT S Tracy
Mar 10, 1998·Research in Veterinary Science·W M Zweers-ZeilmakerA S Van Miert
Apr 4, 1998·Thrombosis Research·Z Y ZhangL S Kaminsky
Dec 29, 2000·Journal of Chromatography. B, Biomedical Sciences and Applications·J M HutzlerT S Tracy
Jul 18, 2001·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·J M HutzlerT S Tracy
Jul 15, 1998·British Journal of Clinical Pharmacology·J O Miners, D J Birkett
May 23, 1998·Journal of Veterinary Pharmacology and Therapeutics·W M Zweers-ZeilmakerR F Witkamp
Oct 11, 2012·Pharmacogenetics and Genomics·Lei HuLan Fan
Aug 25, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Vikas KumarJan L Wahlstrom
Apr 2, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Vikas KumarT S Tracy
Jul 27, 2010·Applied and Environmental Microbiology·Jessica AmadioCormac D Murphy
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·J H Lin, A Y Lu
Jan 11, 2003·Journal of Clinical Pharmacology·Craig R LeeJ A Goldstein
Nov 14, 2007·BMC Evolutionary Biology·Erica J ReschlyMatthew D Krasowski
Aug 29, 2001·Clinical Pharmacokinetics·H Takahashi, H Echizen
Mar 21, 2009·Analytical and Bioanalytical Chemistry·Raluca-Ioana Stefan-van StadenHassan Y Aboul-Enein
Oct 14, 2014·Drug and Chemical Toxicology·Taygun Timocin, Hasan B Ila
Oct 14, 2003·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·B K PatelA J Hutt
Apr 2, 1998·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C E OngC R Bhasker
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Mar 8, 2005·Drug Metabolism Reviews·Haiping HaoJianguo Sun
Oct 24, 2006·British Journal of Clinical Pharmacology·N K ZgheibR A Branch
Sep 3, 2014·Biotechnology Letters·Cormac D Murphy
Jun 8, 2004·The Journal of Biological Chemistry·Michael R WesterEric F Johnson
Feb 2, 2018·Journal of Personalized Medicine·Lindsay M HendersonKenneth E Thummel
Apr 17, 2003·European Journal of Clinical Pharmacology·Craig R LeeJ A Goldstein
Aug 12, 2005·The Journal of Pharmacology and Experimental Therapeutics·Xue-Qing LiTommy B Andersson

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Nodding Syndrome

Nodding Syndrome is a neurological and epileptiform disorder characterized by psychomotor, mental, and growth retardation. Discover the latest research on Nodding Syndrome here.

LRRK2 & Microtubules

Mutations in the LRRK2 gene are risk-factors for developing Parkinson’s disease (PD). LRRK2 mutations in PD have been shown to enhance its association with microtubules. Here is the latest research.